7-Eleven Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:7-Eleven Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2222
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:88
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:小売り
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

7-Eleven Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s 7-Eleven Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by 7-Eleven Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes 7-Eleven Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by 7-Eleven Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on 7-Eleven Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by 7-Eleven Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for 7-Eleven Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about 7-Eleven Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 61
Corporate Venturing – Overview 61
Corporate Venturing – Deal reports 62
DIVESTMENTS 70
Divestments – Overview 70
Divestments – Deal reports 71
APPENDIX 78
Contact Us 78
About MarketLine Financial Deals Database 78
Deal Definition and Methodology 80
About MarketLine 87

List of Tables
Table 1: 7-Eleven M&A volume and value trend (2014-YTD2018)
Table 2: 7-Eleven M&A activity by geography (2014-YTD2018)
Table 3: 7-Eleven corporate venturing volume and value trend (2014-YTD2018)
Table 4: 7-Eleven corporate venturing by geography (2014-YTD2018)
Table 5: 7-Eleven divestments volume and value trend (2014-YTD2018)
Table 6: 7-Eleven divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: 7-Eleven M&A volume and value trend (2014-YTD2018)
Figure 2: 7-Eleven M&A activity by geography (2014-YTD2018)
Figure 3: 7-Eleven corporate venturing volume and value trend (2014-YTD2018)
Figure 4: 7-Eleven corporate venturing by geography (2014-YTD2018)
Figure 5: 7-Eleven divestments volume and value trend (2014-YTD2018)
Figure 6: 7-Eleven divestments by geography (2014-YTD2018)

★海外企業調査レポート[7-Eleven Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Argos SA:企業の戦略・SWOT・財務分析
    Grupo Argos SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Argos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • InMed Pharmaceuticals Inc (IN):企業の財務・戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • Nationale-Nederlanden Levensverzekering Maatschappij N.V.:企業の戦略・SWOT・財務情報
    Nationale-Nederlanden Levensverzekering Maatschappij N.V. - Strategy, SWOT and Corporate Finance Report Summary Nationale-Nederlanden Levensverzekering Maatschappij N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the co …
  • Lonestar Heart Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lonestar Heart Inc (Lonestar Heart) is a pharmaceutical company that focuses on the development of novel cardiac restorative therapies for advanced heart failure. The company offers Algisyl cardiac implantable hydrogel and MyoTec system. Its Algisyl product provides a new treatment option fo …
  • Litani River Authority:企業の戦略的SWOT分析
    Litani River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Agfa-Gevaert N.V.:企業の戦略・SWOT・財務情報
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • A. O. Smith Corporation (AOS):企業の財務・戦略的SWOT分析
    A. O. Smith Corporation (AOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • SeraCare Life Sciences Inc:企業の戦略的SWOT分析
    SeraCare Life Sciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • APR Applied Pharma Research SA-製薬・医療分野:企業M&A・提携分析
    Summary APR Applied Pharma Research SA (APR) is a healthcare company which focuses on the development and licenses of healthcare products for rare therapeutic areas. The company offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfol …
  • Duke Energy Carolinas LLC:発電所・企業SWOT分析
    Duke Energy Carolinas LLC – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Boyd Gaming Corporation:企業の戦略・SWOT・財務分析
    Boyd Gaming Corporation - Strategy, SWOT and Corporate Finance Report Summary Boyd Gaming Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Enercon GmbH-エネルギー分野:企業M&A・提携分析
    Summary Enercon GmbH (Enercon) is a renewable energy equipment company that manufactures and supplies wind energy converters (WEC). It produces components of the WECs including annular generators, inverters, rotor blades, cast components, towers and machine houses. Enercon provides electrical and me …
  • Carrols Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Carrols Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrols Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Air Liquide SA (AI)-エネルギー分野:企業M&A・提携分析
    Summary Air Liquide SA (Air Liquide) is a provider of gases, technologies and services for industry and health. The company produces core air gases such as oxygen, nitrogen, and hydrogen along with argon and other rare gases. It supplies gases to customers in multiple industries, including steel, ch …
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874):企業の財務・戦略的SWOT分析
    Summary Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (Guangzhou Baiyunshan Pharmaceutical) is a manufacturer of herbal medicine, chemical raw material medicine and preparation, biological medicine, and health products. The company also offers health medicines, health beverages, Chinese and we …
  • Arthrex Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company that designs and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and wr …
  • Den-Mat Holdings LLC-医療機器分野:企業M&A・提携分析
    Summary Den-Mat Holdings LLC (Den-Mat) is a medical device company that develops and manufactures dental products. The company provides products such as curing lights, finishing and polishing, impressions, instruments, lesion detection, magnification/illumination, oral hygiene, restoratives, soft ti …
  • DZ HYP AG:企業の戦略・SWOT・財務分析
    DZ HYP AG - Strategy, SWOT and Corporate Finance Report Summary DZ HYP AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆